Immunocore Holdings plc - ADR (IMCR)

CUSIP: 45258D105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / ADR
Shares outstanding
50,698,400
Total 13F shares
45,410,647
Share change
-89,437
Total reported value
$1,339,563,608
Put/Call ratio
67%
Price per share
$29.50
Number of holders
114
Value change
-$4,915,367
Number of buys
45
Number of sells
70

Quarterly Holders Quick Answers

What is CUSIP 45258D105?
CUSIP 45258D105 identifies IMCR - Immunocore Holdings plc - ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMCR - Immunocore Holdings plc - ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
14%
7,048,833
$219,430,172 30 Sep 2024
13F
T. Rowe Price Investment Management, Inc.
13F
Company
13%
6,499,835
$202,340,000 30 Sep 2024
13F
RTW INVESTMENTS, LP
13F
Company
9.6%
4,869,798
$151,596,812 30 Sep 2024
13F
FMR LLC
13F
Company
9.5%
4,836,040
$150,545,927 30 Sep 2024
13F
Jallal Bahija
13D/G
8.2%
4,493,139
$135,513,072 $0 31 Dec 2024
PRIMECAP MANAGEMENT CO/CA/
13F
Company
4.9%
2,472,020
$76,953,983 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
4.3%
2,157,698
$67,170,000 30 Sep 2024
13F
BAKER BROS. ADVISORS LP
13F
Company
3%
1,515,318
$47,171,849 30 Sep 2024
13F
ARMISTICE CAPITAL, LLC
13F
Company
2.5%
1,264,000
$39,348,320 30 Sep 2024
13F
GENERAL ATLANTIC, L.P.
13F
Individual
2.5%
1,261,684
$39,276,223 30 Sep 2024
13F
Bellevue Group AG
13F
Company
2.4%
1,205,464
$37,526,094 30 Sep 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
2.2%
1,105,600
$34,417,328 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
1.7%
873,611
$27,195,510 30 Sep 2024
13F
Fiera Capital Corp
13F
Company
1.7%
845,732
$26,327,637 30 Sep 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
1.5%
757,700
$23,587,201 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.3%
676,631
$21,063,523 30 Sep 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
1.2%
597,142
$18,589,030 30 Sep 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
1.1%
546,318
$17,006,858 30 Sep 2024
13F
Polar Capital Holdings Plc
13F
Company
0.99%
501,755
$15,619,633 30 Sep 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.98%
498,221
$15,509,620 30 Sep 2024
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.84%
427,152
$13,297,000 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.8%
404,825
$12,602,215 30 Sep 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.62%
312,952
$9,826,693 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.56%
284,939
$8,870,144 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.54%
276,200
$8,598,106 30 Sep 2024
13F
Woodline Partners LP
13F
Company
0.54%
274,681
$8,550,820 30 Sep 2024
13F
Hudson Bay Capital Management LP
13F
Company
0.49%
247,300
$7,698,449 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.45%
226,341
$7,045,995 30 Sep 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.4%
202,806
$6,313,351 30 Sep 2024
13F
Avidity Partners Management LP
13F
Company
0.39%
200,000
$6,226,000 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
0.39%
199,443
$6,208,659 30 Sep 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.38%
191,541
$5,962,671 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.34%
172,067
$5,356,446 30 Sep 2024
13F
S.c.a. Candriam
13F
Individual
0.28%
140,006
$4,358,192 30 Sep 2024
13F
Legal & General Group Plc
13F
Company
0.23%
116,712
$3,633,244 30 Sep 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.22%
112,199
$3,492,755 30 Sep 2024
13F
Frazier Life Sciences Management, L.P.
13F
Company
0.21%
108,762
$3,385,761 30 Sep 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.21%
107,391
$3,343,082 30 Sep 2024
13F
CANTOR FITZGERALD, L. P.
13F
Individual
0.2%
101,942
$3,173,454 30 Sep 2024
13F
AXA S.A.
13F
Company
0.19%
95,040
$2,958,595 30 Sep 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.18%
92,257
$2,871,961 30 Sep 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.16%
83,055
$2,585,503 30 Sep 2024
13F
Pier Capital, LLC
13F
Company
0.16%
82,480
$2,567,602 30 Sep 2024
13F
STATE STREET CORP
13F
Company
0.15%
76,671
$2,386,768 30 Sep 2024
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.14%
72,980
$2,271,867 30 Sep 2024
13F
Squarepoint Ops LLC
13F
Company
0.14%
72,068
$2,243,477 30 Sep 2024
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.13%
65,539
$2,040,229 30 Sep 2024
13F
Jump Financial, LLC
13F
Company
0.12%
60,622
$1,887,163 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.12%
59,108
$1,840,032 30 Sep 2024
13F
Rhenman & Partners Asset Management AB
13F
Company
0.11%
58,278
$1,814,194 30 Sep 2024
13F

Institutional Holders of Immunocore Holdings plc - ADR (IMCR) as of Q4 2024

As of 31 Dec 2024, Immunocore Holdings plc - ADR (IMCR) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,410,647 shares. The largest 10 holders included T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, FMR LLC, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, TANG CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, GENERAL ATLANTIC, L.P., and Kynam Capital Management, LP. This page lists 115 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
129
Q4 2024 holders
114
Holder diff
-15
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .